Human Papillomavirus and Gardasil
| dc.contributor.author | Patel, Elena | en |
| dc.contributor.author | Ghebremichael, Mecal | en |
| dc.contributor.author | Sutherland, Aimee | en |
| dc.date.accessioned | 2017-11-10T17:43:29Z | en |
| dc.date.available | 2017-11-10T17:43:29Z | en |
| dc.date.issued | 2013-10 | en |
| dc.description.abstract | Human Papillomavirus (HPV) is the most common sexual transmitted disease (STD), with 79 million Americans currently infected and 14 million new infections occurring annually... The pharmaceutical company Merck developed the Gardasil vaccine to protect individuals against four strains of HPV that cause genital warts and various cancers. | en |
| dc.identifier.uri | http://hdl.handle.net/10919/80306 | en |
| dc.language.iso | en_US | en |
| dc.publisher | Virginia Tech | en |
| dc.relation.ispartofseries | VRG Information Sheets; | en |
| dc.rights | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 United States | en |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | en |
| dc.title | Human Papillomavirus and Gardasil | en |
| dc.type | Report | en |